2. GPCR/G Protein Neuronal Signaling
  3. CGRP Receptor
  4. Fremanezumab

Fremanezumab  (Synonyms: TEV-48125)

Cat. No.: HY-P99019 Purity: 95.00%
Data Sheet
SDS
COA
Technical Support

Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research.

For research use only. We do not sell to patients.

CAS No. : 1655501-53-3

Size Price Stock Quantity
1 mg USD 250 In-stock
5 mg USD 700 In-stock
10 mg USD 1100 In-stock
50 mg   Get quote  
100 mg   Get quote  

Get it by April 4 for select sizes. Order within 22 hrs 39 mins.

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Fremanezumab Featured Recommendations:

Fremanezumab Related Antibodies

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Fremanezumab

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research[1].

Isotype

Human IgG2 kappa
Recommend Isotype Controls
Species

Humanized
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT03965091Teva Branded Pharmaceutical Products R&D, Inc.
Fibromyalgia
July 31, 2019Phase 2
NCT03107052Teva Branded Pharmaceutical Products R&D, Inc.
Cluster Headache
April 27, 2017Phase 3
NCT04693533Beth Israel Deaconess Medical Center|Teva Pharmaceuticals USA
Migraine Disorders|Sleep Disorder
July 29, 2021Phase 4
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Fremanezumab]
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG2 kappa
Purity & Documentation

Purity: 95.00%

Data Sheet (255 KB) SDS (251 KB)

COA (291 KB)

Inhibitory Antibodies User Guide (602 KB)
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Fremanezumab Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

Fremanezumab1655501-53-3TEV-48125TEV48125TEV 48125CGRP ReceptorCalcitonin gene-related peptide receptorhumanized IgG2acalcitonin gene-related peptideCGRPneuropeptidemigraineInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Fremanezumab
Cat. No.:
HY-P99019
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.